Double-blind placebo controlled clinical
β
I. Bakran; B. Vrhovac; B. Ε tangl; Δ. Tabori; A. IviΔevic; V. TodiΔ; F. Kandare
π
Article
π
1990
π
Springer
π
English
β 518 KB
The efficacy and safety of almitrine bismesylate, a new respiratory stimulant, in patients with the hypoxaemic form of chronic respiratory insufficiency caused by chronic bronchitis and emphysema has been assessed. The multicentre trial of 12 weeks duration was double-blind and placebo controlled, w